NCT04970758

Brief Summary

Assess the effects of strength sport to heart structure and function by T1 mapping with cardiac resonance imaging.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 16, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2019

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2020

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

June 28, 2021

Completed
23 days until next milestone

First Posted

Study publicly available on registry

July 21, 2021

Completed
Last Updated

July 21, 2021

Status Verified

June 1, 2021

Enrollment Period

10 months

First QC Date

June 28, 2021

Last Update Submit

July 12, 2021

Conditions

Athlete's Heart

Outcome Measures

Primary Outcomes (1)

  • T1 value in ms (Unit)

    indicator of the degree of myocardial fibrosis

    one year

Study Arms (2)

study group

Athletes /strength exercise

control group

Eligibility Criteria

Age18 Years - 35 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Athletes

You may qualify if:

  • Same exercise

You may not qualify if:

  • Intolerance test

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University Third Hospital

Beijing, Beijing Municipality, 100191, China

Location

Study Officials

  • xinyu wang, MD

    Peking University Third Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 28, 2021

First Posted

July 21, 2021

Study Start

January 16, 2019

Primary Completion

November 1, 2019

Study Completion

December 12, 2020

Last Updated

July 21, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations

CN(1)